Mpox: evidence for strengthening and sustaining global surveillance

Affiliations

¹ NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, UK; UK Health Security Agency Rare and Imported Pathogens Laboratory, Porton Down SP4 0JG, UK.
² UK Health Security Agency Rare and Imported Pathogens Laboratory, Porton Down SP4 0JG, UK. Electronic address: claire.gordon@ukhsa.gov.uk.

Free article

Comment

Helen Callaby et al. Lancet Glob Health. 2023 Jul.

Free article

. 2023 Jul;11(7):e983-e984.

doi: 10.1016/S2214-109X(23)00241-3.

¹ NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, UK; UK Health Security Agency Rare and Imported Pathogens Laboratory, Porton Down SP4 0JG, UK.
² UK Health Security Agency Rare and Imported Pathogens Laboratory, Porton Down SP4 0JG, UK. Electronic address: claire.gordon@ukhsa.gov.uk.

No abstract available

Conflict of interest statement

We declare no competing interests.

Description of the first global outbreak of mpox: an analysis of global surveillance data.
Laurenson-Schafer H, Sklenovská N, Hoxha A, Kerr SM, Ndumbi P, Fitzner J, Almiron M, de Sousa LA, Briand S, Cenciarelli O, Colombe S, Doherty M, Fall IS, García-Calavaro C, Haussig JM, Kato M, Mahamud AR, Morgan OW, Nabeth P, Naiene JD, Navegantes WA, Ogundiran O, Okot C, Pebody R, Matsui T, Ramírez HL, Smallwood C, Tasigchana RFP, Vaughan AM, Williams GS; WHO mpox Surveillance and Analytics team; Mala PO, Lewis RF, Pavlin BI, le Polain de Waroux O. Laurenson-Schafer H, et al. Lancet Glob Health. 2023 Jul;11(7):e1012-e1023. doi: 10.1016/S2214-109X(23)00198-5. Lancet Glob Health. 2023. PMID: 37349031 Free PMC article.